menu search

Dow industrials run friday gain to 310 points as 26 of 30 components move upward

Dow industrials run Friday gain to 310 points as 26 of 30 components move upward Read Full Story The po...

November 4, 2023, 4:59 pm

: u.s. stocks close higher friday, score biggest weekly gains in about a year

U.S. stocks closed sharply higher Friday, extending a monster rally in equities that saw the big three indexes sweep to their biggest weekly gains of ...

November 4, 2023, 4:14 pm

Xli: diversified cyclicals looking better on valuation, bullish seasonal tailwinds (rating upgrade)

The Industrials sector in the S&P 500 is diverse, featuring both conglomerates and niche firms. The Ind...

November 4, 2023, 10:53 am

1 under-the-radar stock that could triple by 2030

Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in phase 2 cl...

November 4, 2023, 7:30 am

This dividend growth stock has a problem the market is missing right now

Fastenal's third-quarter earnings led to a 7.5% stock price advance on the day of the release. While Wall Street was clearly pleased with the indus...

November 4, 2023, 6:06 am

Fibra macquarie: heavily exposed to nearshoring trend

FIBRA Macquarie is a real estate investment trust in Mexico focused on industrial, commercial, and offi...

November 4, 2023, 1:50 am

Path final deadline: rosen, national trial lawyers, encourages uipath, inc. investors to secure counsel before important deadline in securities class action – path

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of UiPath, Inc...

November 4, 2023, 1:00 am

Investors sue barclays for inaccurately disclosing ex-ceo’s ties to jeffrey epstein – hagens berman

HAGENS BERMAN, NATIONAL trial ATTORNEYS, Encourages Barclays PLC (BCS) Investors with Substantial Losse...

November 4, 2023, 12:22 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Rosen, national trial lawyers, encourages purecycle technologies, inc. investors to secure counsel before important deadline in securities class action – pct, pcttw, pcttu

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PureCycle Tec...

November 3, 2023, 11:20 pm

Rosen, national trial counsel, encourages farfetch limited investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ftch

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Farfetch Limi...

November 3, 2023, 9:12 pm

Rosen, leading trial attorneys, encourages adapthealth corp. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ahco

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...

November 3, 2023, 8:54 pm

Astec to present at baird’s 2023 global industrial conference

CHATTANOOGA, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced today that Jaco van der Merwe, President and Ch...

November 3, 2023, 8:01 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial...

November 3, 2023, 8:01 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fu...

November 3, 2023, 7:31 pm


Search within

Pages Search Results: